AN2 Total Assets vs Non Currrent Assets Other Analysis

ANTX Stock  USD 1.09  0.02  1.80%   
AN2 Therapeutics financial indicator trend analysis is way more than just evaluating AN2 Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AN2 Therapeutics is a good investment. Please check the relationship between AN2 Therapeutics Total Assets and its Non Currrent Assets Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.

Total Assets vs Non Currrent Assets Other

Total Assets vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AN2 Therapeutics Total Assets account and Non Currrent Assets Other. At this time, the significance of the direction appears to have pay attention.
The correlation between AN2 Therapeutics' Total Assets and Non Currrent Assets Other is -0.85. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of AN2 Therapeutics, assuming nothing else is changed. The correlation between historical values of AN2 Therapeutics' Total Assets and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of AN2 Therapeutics are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Assets i.e., AN2 Therapeutics' Total Assets and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

-0.85
Relationship DirectionNegative 
Relationship StrengthSignificant

Total Assets

Total assets refers to the total amount of AN2 Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AN2 Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from AN2 Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AN2 Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.At this time, AN2 Therapeutics' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 100.21 in 2024, whereas Selling General Administrative is likely to drop slightly above 7.7 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Income69K1.4M1.6M1.6M
Net Interest Income69K1.4M1.6M1.6M

AN2 Therapeutics fundamental ratios Correlations

-0.790.860.880.750.78-0.88-0.920.930.870.990.810.190.940.331.0-0.960.730.830.99-0.85-0.86-0.56-0.56-0.56-0.56
-0.79-0.76-0.77-0.49-0.550.750.8-0.81-0.7-0.8-0.59-0.44-0.82-0.57-0.80.85-0.55-0.64-0.830.690.690.530.530.530.53
0.86-0.761.00.880.89-0.72-0.990.970.670.840.94-0.010.750.150.84-0.820.940.940.86-0.84-0.98-0.9-0.9-0.9-0.9
0.88-0.771.00.890.9-0.76-1.00.980.710.860.930.010.780.170.86-0.850.930.940.89-0.86-0.98-0.88-0.88-0.88-0.88
0.75-0.490.880.891.0-0.73-0.870.870.70.740.85-0.430.66-0.270.74-0.640.960.980.76-0.91-0.96-0.79-0.79-0.79-0.79
0.78-0.550.890.91.0-0.78-0.890.890.750.780.84-0.380.71-0.220.78-0.680.950.990.8-0.94-0.96-0.77-0.77-0.77-0.77
-0.880.75-0.72-0.76-0.73-0.780.8-0.87-0.99-0.92-0.55-0.11-0.97-0.24-0.920.89-0.61-0.8-0.930.940.770.450.450.450.45
-0.920.8-0.99-1.0-0.87-0.890.8-0.99-0.75-0.9-0.92-0.04-0.83-0.21-0.90.88-0.91-0.94-0.920.880.980.840.840.840.84
0.93-0.810.970.980.870.89-0.87-0.990.830.930.860.080.890.240.93-0.920.870.930.96-0.92-0.96-0.79-0.79-0.79-0.79
0.87-0.70.670.710.70.75-0.99-0.750.830.910.510.10.960.220.91-0.870.550.760.92-0.92-0.73-0.37-0.37-0.37-0.37
0.99-0.80.840.860.740.78-0.92-0.90.930.910.760.210.970.351.0-0.970.690.820.99-0.87-0.84-0.53-0.53-0.53-0.53
0.81-0.590.940.930.850.84-0.55-0.920.860.510.76-0.140.60.020.76-0.70.940.870.76-0.7-0.93-0.83-0.83-0.83-0.83
0.19-0.44-0.010.01-0.43-0.38-0.11-0.040.080.10.21-0.140.290.990.21-0.4-0.34-0.280.220.170.170.130.130.130.13
0.94-0.820.750.780.660.71-0.97-0.830.890.960.970.60.290.420.97-0.960.570.750.97-0.87-0.76-0.44-0.44-0.44-0.44
0.33-0.570.150.17-0.27-0.22-0.24-0.210.240.220.350.020.990.420.35-0.54-0.18-0.120.370.020.0-0.02-0.02-0.02-0.02
1.0-0.80.840.860.740.78-0.92-0.90.930.911.00.760.210.970.35-0.970.690.820.99-0.87-0.84-0.53-0.53-0.53-0.53
-0.960.85-0.82-0.85-0.64-0.680.890.88-0.92-0.87-0.97-0.7-0.4-0.96-0.54-0.97-0.62-0.74-0.980.80.790.560.560.560.56
0.73-0.550.940.930.960.95-0.61-0.910.870.550.690.94-0.340.57-0.180.69-0.620.960.72-0.81-0.97-0.9-0.9-0.9-0.9
0.83-0.640.940.940.980.99-0.8-0.940.930.760.820.87-0.280.75-0.120.82-0.740.960.84-0.94-0.98-0.81-0.81-0.81-0.81
0.99-0.830.860.890.760.8-0.93-0.920.960.920.990.760.220.970.370.99-0.980.720.84-0.89-0.87-0.59-0.59-0.59-0.59
-0.850.69-0.84-0.86-0.91-0.940.940.88-0.92-0.92-0.87-0.70.17-0.870.02-0.870.8-0.81-0.94-0.890.90.640.640.640.64
-0.860.69-0.98-0.98-0.96-0.960.770.98-0.96-0.73-0.84-0.930.17-0.760.0-0.840.79-0.97-0.98-0.870.90.860.860.860.86
-0.560.53-0.9-0.88-0.79-0.770.450.84-0.79-0.37-0.53-0.830.13-0.44-0.02-0.530.56-0.9-0.81-0.590.640.861.01.01.0
-0.560.53-0.9-0.88-0.79-0.770.450.84-0.79-0.37-0.53-0.830.13-0.44-0.02-0.530.56-0.9-0.81-0.590.640.861.01.01.0
-0.560.53-0.9-0.88-0.79-0.770.450.84-0.79-0.37-0.53-0.830.13-0.44-0.02-0.530.56-0.9-0.81-0.590.640.861.01.01.0
-0.560.53-0.9-0.88-0.79-0.770.450.84-0.79-0.37-0.53-0.830.13-0.44-0.02-0.530.56-0.9-0.81-0.590.640.861.01.01.0
Click cells to compare fundamentals

AN2 Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for AN2 Stock Analysis

When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.